Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-marketing, Twelve Weeks, Open Label Study of up to 40 mg. Escitalopram in Chronic PTSD

NCT00736021 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT00736021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00736021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-marketing, Twelve Weeks, Open Label Study of up to 40 mg. Escitalopram in Chronic PTSD
Lead sponsor
Hadassah Medical Organization
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2008
Completion date
March 31, 2010
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stress disorders, post traumatic